Mosunetuzumab

Definition: Mosunetuzumab, sold under the brand name Lunsumio, is a monoclonal antibody used for the treatment of follicular lymphoma. It bispecifically binds CD20 and CD3 to engage T-cells. It was developed by Genentech. source: Wikipedia

ID

278181000202107

ID date

16 May 2024

Previous ID

41129511000001103

Name

Mosunetuzumab